Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapy.
Krug D, Vladimirova V, Untch M, Kühn T, Schneeweiss A, Denkert C, Ataseven B, Solbach C, Gerber B, Tesch H, Golatta M, Seiler S, Heil J, Nekljudova V, Holtschmidt J, Loibl S. Krug D, et al. Among authors: vladimirova v. Breast. 2024 Apr;74:103701. doi: 10.1016/j.breast.2024.103701. Epub 2024 Feb 24. Breast. 2024. PMID: 38422624 Free PMC article.
Locoregional recurrence risk after neoadjuvant chemotherapy: A pooled analysis of nine prospective neoadjuvant breast cancer trials.
Werutsky G, Untch M, Hanusch C, Fasching PA, Blohmer JU, Seiler S, Denkert C, Tesch H, Jackisch C, Gerber B, Schneeweiss A, Link T, Krug D, Huober J, Rhiem K, Kühn T, Vladimirova V, Nekljudova V, Loibl S. Werutsky G, et al. Among authors: vladimirova v. Eur J Cancer. 2020 May;130:92-101. doi: 10.1016/j.ejca.2020.02.015. Epub 2020 Mar 13. Eur J Cancer. 2020. PMID: 32179450
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy.
Leichsenring J, Vladimirova V, Solbach C, Karn T, Ataseven B, Sinn BV, Barinoff J, Müller V, Blohmer JU, Schem C, Engels K, Marmé F, Fisseler-Eckhoff A, Fasching PA, Stickeler E, van Mackelenbergh M, Denkert C, Stenzinger A, Loibl S, Gröschel S. Leichsenring J, et al. Among authors: vladimirova v. BMC Cancer. 2022 Oct 5;22(1):1040. doi: 10.1186/s12885-022-10109-1. BMC Cancer. 2022. PMID: 36195836 Free PMC article.
TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
Stürken C, Möbus V, Milde-Langosch K, Schmatloch S, Fasching PA, Rüschoff J, Stickeler E, Henke RP, Denkert C, Hanker L, Schem C, Vladimirova V, Karn T, Nekljudova V, Köhne CH, Marmé F, Schumacher U, Loibl S, Müller V. Stürken C, et al. Among authors: vladimirova v. BMC Cancer. 2021 Aug 14;21(1):920. doi: 10.1186/s12885-021-08656-0. BMC Cancer. 2021. PMID: 34391399 Free PMC article.
Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial.
Llop-Guevara A, Loibl S, Villacampa G, Vladimirova V, Schneeweiss A, Karn T, Zahm DM, Herencia-Ropero A, Jank P, van Mackelenbergh M, Fasching PA, Marmé F, Stickeler E, Schem C, Dienstmann R, Florian S, Nekljudova V, Balmaña J, Hahnen E, Denkert C, Serra V. Llop-Guevara A, et al. Among authors: vladimirova v. Ann Oncol. 2021 Dec;32(12):1590-1596. doi: 10.1016/j.annonc.2021.09.003. Epub 2021 Sep 11. Ann Oncol. 2021. PMID: 34520831 Free article.
mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease.
Wege AK, Rom-Jurek EM, Jank P, Denkert C, Ugocsai P, Solbach C, Blohmer JU, Sinn B, van Mackelenbergh M, Möbus V, Trumpp A, Marangoni E, Pfarr N, Irlbeck C, Warfsmann J, Polzer B, Weber F, Ortmann O, Loibl S, Vladimirova V, Brockhoff G. Wege AK, et al. Among authors: vladimirova v. Int J Cancer. 2022 Apr 15;150(8):1357-1372. doi: 10.1002/ijc.33911. Epub 2021 Dec 28. Int J Cancer. 2022. PMID: 34927257 Free article.
Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
Stürken C, Möbus V, Milde-Langosch K, Schmatloch S, Fasching PA, Rüschoff J, Stickeler E, Henke RP, Denkert C, Hanker L, Schem C, Vladimirova V, Karn T, Nekljudova V, Köhne CH, Marmé F, Schumacher U, Loibl S, Müller V. Stürken C, et al. Among authors: vladimirova v. BMC Cancer. 2021 Sep 15;21(1):1024. doi: 10.1186/s12885-021-08754-z. BMC Cancer. 2021. PMID: 34526003 Free PMC article. No abstract available.
[Clinical features, diagnostics and treatment of FGF23 secreting tumors: series of 40 clinical cases].
Gronskaia SA, Belaya ZE, Rozhinskaya LY, Melnichenko GA, Dubovitskaya TA, Mamedova EO, Rodionova SS, Buklemishev YV, Pigarova EA, Degtyarev MV, Babaeva DM, Vladimirova VP, Tarbaeva NV, Serzhenko SS, Grigoriev AY, Dzeranova LK, Karpenko VY, Karasev AL, Fedotov RN, Uliyanova IN, Toroptsova NV, Lesnyak OM, Mokrysheva NG, Dedov II. Gronskaia SA, et al. Among authors: vladimirova vp. Probl Endokrinol (Mosk). 2023 Nov 10;69(5):25-38. doi: 10.14341/probl13221. Probl Endokrinol (Mosk). 2023. PMID: 37968949 Free PMC article. Russian.
[Olfactory function and olfactory bulbs in patients with Kallmann syndrome].
Kokoreva KD, Chugunov IS, Vladimirova VP, Ivannikova TE, Bogdanov VP, Bezlepkina OB. Kokoreva KD, et al. Among authors: vladimirova vp. Probl Endokrinol (Mosk). 2023 May 11;69(2):67-74. doi: 10.14341/probl13216. Probl Endokrinol (Mosk). 2023. PMID: 37448273 Free PMC article. Russian.
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Cochrane T, Chary S, Chew S, Zhu H, Wu F, Nestorov I, Graham D, Sun P, McNeill M, Fanning L, Ferguson TA, Fradette S; VALOR and OLE Working Group. Miller TM, et al. N Engl J Med. 2022 Sep 22;387(12):1099-1110. doi: 10.1056/NEJMoa2204705. N Engl J Med. 2022. PMID: 36129998 Free article. Clinical Trial.
76 results